Molecular targeting by homocysteine: a mechanism for vascular pathogenesis
- 1 January 2005
- journal article
- review article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 43 (10) , 1076-1083
- https://doi.org/10.1515/cclm.2005.188
Abstract
Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Although there is a growing body of evidence that homocysteine plays a causal role in atherogenesis, specific mechanisms to explain the underlying pathology have remained elusive. This review focuses on chemistry unique to the homocysteine molecule to explain its inherent cytotoxicity. Thus, the high pKa of the sulfhydryl group (pKa=10.0) of homocysteine underlies its ability to form stable disulfide bonds with protein cysteine residues, and in the process, alters or impairs the function of the protein. Albumin, fibronectin, transthyretin, annexin II, and factor V have now been identified as molecular targets for homocysteine, and in the case of albumin, the mechanism of targeting has been elucidated.Keywords
This publication has 63 references indexed in Scilit:
- Effect of hyperhomocysteinemia on protein C activation and activityBlood, 2002
- Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein ResponseJournal of Biological Chemistry, 2001
- Homocysteine Inhibits Inactivation of Factor Va by Activated Protein CJournal of Biological Chemistry, 2001
- Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial diseaseJournal of Vascular Surgery, 1999
- Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuriaKidney International, 1999
- A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project ParticipantsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Methionine metabolism in mammalsThe Journal of Nutritional Biochemistry, 1990
- Protein‐bound plasma homocyst(e)ine and identification of heterozygotes for cystathionine‐synthase deficiencyJournal of Inherited Metabolic Disease, 1985
- The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Journal of Clinical Investigation, 1976